Rethinking antibody discovery in the age of automation
James Atwood, COO of Opentrons, shares how accessible lab automation is helping research teams tackle tighter budgets, faster timelines and complex discovery workflows.
List view / Grid view
James Atwood, COO of Opentrons, shares how accessible lab automation is helping research teams tackle tighter budgets, faster timelines and complex discovery workflows.
In this interview with Jose-Manuel Collados, learn how ABB's strategic partnerships and automation technology are improving lab efficiency, enhancing precision and ultimately speeding up the development of life-saving treatments.
Researchers from China have formulated a robotics system that can access areas in the lung non-invasively before cancer diagnosis.
A report has found that increased investment in drug discovery will help the demand for personalised medicine, encouraging the growth of the liquid handling market.
An automated intracellular sensing system could provide an efficient approach to reveal the cellular characteristics of disease progression.
A capsule that tunnels through mucus in the gastrointestinal tract could be used to orally administer large protein drugs such as insulin.
30 June 2022 | By Brooks Automation
Watch this on-demand webinar to learn how collaborative robots are improving accuracy and efficiency in today’s laboratories.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
In this latest episode, we discuss how small molecule discovery can be automated and how this process saves researchers time and money.
View Drug Target Review's new infographic on the use of AI and informatics within early therapeutic development here.
Nanoengineers have developed a high-throughput bioprinter that 3D prints at record speed, potentially accelerating drug development.
Researchers have developed software that can design complex DNA nanodevices which could be used to deliver medicine while in the body.
A flow mode Raman-activated cell sorter called FlowRACS has been created by researchers for high-throughput discovery of enzymes and their cell factories.
The autonomous robot scientist can independently perform experimental procedures and makes its own decisions about which tests to perform.
The future of drug discovery lies in an automated world where the workflows for biological assays, chemical synthesis and data analysis are connected by flexible, mobile and modular hardware, integrated with software solutions that will interface with scientists for increased efficiency and productivity (the realisation of Industry 4.0). This article…